Showing results (111-120 of 360) with videos related to

Sort By:
Pageof 36
BMC Urology|June 9, 2016
Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancerJean-Baptiste Beauval, Mathieu Roumiguié, Thomas Filleron, et al.
BJU International|November 26, 2009
Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancerGuillaume Ploussard, Laurent Salomon, Yves Allory, et al.
World Journal of Urology|September 3, 2014
Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapyAlexandra Masson-Lecomte, Evanguelos Xylinas, Morgane Bouquot, et al.
World Journal of Urology|September 10, 2020
Preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemicUgo Pinar, Julien Anract, Ophélie Perrot, et al.
The Journal of Urology|April 19, 2011
Clinical evaluation of the PCA3 assay in guiding initial biopsy decisionsAlexandre de la Taille, Jacques Irani, Markus Graefen, et al.
World Journal of Urology|May 20, 2006
Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxinAbdel-Rahmène Azzouzi, Marc Fourmarier, Francois Desgrandchamps, et al.
Scandinavian Journal of Urology|July 26, 2013
Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: ten years of follow-upMathieu Rouanne, Julie Rode, Alexandre Campeggi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2013
Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective studyAlexandre Campeggi, Idir Ouzaid, Evanguelos Xylinas, et al.
BJU International|December 24, 2010
Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy schemeGuillaume Ploussard, Evanguelos Xylinas, Xavier Durand, et al.
Urology|March 26, 2013
Clinical judgment versus biomarker prostate cancer gene 3: which is best when determining the need for repeat prostate biopsy?Bertrand Tombal, Gerald L Andriole, Alexandre de la Taille, et al.
Pageof 36